Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint No anti-drug antibodies (ADA): no immune rejection of the DMAbs was detected across ~1,000 blood samples, unlike other gene-based antibody delivery…

ALBUQUERQUE, N.M., March 13, 2025 /PRNewswire/ — Today, the Public Utility Commission of Texas (PUCT) approved the 2025-2027 System Resiliency Plan filed by TNMP, a wholly-owned subsidiary of TXNM Energy (NYSE: TXNM). Under the plan, TNMP will invest $545.8 million over three years to…

NEW YORK, March 13, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.